Document Classification

Section Type: RESULTS

Text: At endpoint, subjects who received ondansetron + naltrexone (n = 10), compared with those who received placebo (n = 10), had fewer drinks/day (covariate adjusted mean 0. 99 + / - 0. 60 vs. 3. 68 + / - 0. 63 ; F1, 16 = 9. 35, p = 0. 008 ; effect size = 1. 42), drinks/drinking day (covariate adjusted mean 3. 14 + / - 0. 87 vs. 6. 76 + / - 0. 71 ; F1, 13 = 10. 45, p = 0. 007 ; effect size = 1. 71), and a trend toward increased percent days abstinent (covariate adjusted mean 69. 76 + / - 8. 64 vs. 48. 24 + / - 9. 12 ; F1, 16 = 3. 58, p = 0. 08 ; effect size = 0. 88).